Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organic oxygen compounds
(total 14 related compounds in database, current show from 1 to 10)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
N-methyl-3-[3-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzamide Depiction based on curated SMILES O OH OH HO HO H 3 C O CH 3 O NH Escherichia Type 1 fimbriae Preclinical (in vivo) Cusumano CK, et al. 2011. Sci Transl Med; Jarvis C, et al. 2016. ChemMedChem
Aurodox Depiction based on curated SMILES O CH 3 O OH HO OH H 3 C H N O OH OH OH H 3 C H 3 C CH 3 O H H H H H 3 C CH 3 NH O H H H 3 C O CH 3 H H H Escherichia TTSS (Type III secretion system) Preclinical (in vivo) Kimura K, et al. 2011. J Antibiot (Tokyo)
1-N,3-N-dimethyl-5-[3-(trifluoromethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzene-1,3-dicarboxamide Depiction based on curated SMILES F O O HO F HO HO OH NH NH O O CH 3 CH 3 F Escherichia Type 1 fimbriae Preclinical (in vivo) Cusumano CK, et al. 2011. Sci Transl Med
1-N,3-N-dimethyl-5-[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzene-1,3-dicarboxamide Depiction based on curated SMILES OH HO HO HO O O CH 3 CH 3 NH O O NH Escherichia Type 1 fimbriae Preclinical (in vivo) Cusumano CK, et al. 2011. Sci Transl Med
3-[3-chloro-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-N-methylbenzamide Depiction based on curated SMILES O OH OH HO HO H 3 C O Cl O NH Escherichia Type 1 fimbriae Preclinical (in vivo) Cusumano CK, et al. 2011. Sci Transl Med
N-methyl-3-[3-(trifluoromethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzamide Depiction based on curated SMILES OH OH HO HO O H 3 C O F F F O NH Escherichia Type 1 fimbriae Preclinical (in vivo) Cusumano CK, et al. 2011. Sci Transl Med
[3,4,5-trihydroxy-6-[2-methyl-4-[3-(methylcarbamoyl)phenyl]phenoxy]oxan-2-yl]methyl dihydrogen phosphate Depiction based on curated SMILES P O OH HO HO OH O OH CH 3 H 3 C O O O N H Escherichia Type 1 fimbriae Preclinical (in vivo) Mydock-McGrane L, et al. 2016. J Med Chem
1-N,3-N-dimethyl-5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzene-1,3-dicarboxamide Depiction based on curated SMILES H H H H O H HO HO HO OH O NH CH 3 NH O CH 3 O Escherichia Type 1 fimbriae Preclinical (in vitro) Han Z, et al. 2010. J Med Chem
Bio8B6 Depiction based on curated SMILES HO Cl Cl H 3 C N Cl O Escherichia TTSS (Type III secretion system) Preclinical (in vitro) Gauthier A, et al. 2005. Antimicrob Agents Chemother
3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-N-[2-[2-[2-[[3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzoyl]amino]ethoxy]ethoxy]ethyl]benzamide Depiction based on curated SMILES OH OH OH OH O H H H H OH OH OH OH O H H H H H O N H O O HN O H O O Escherichia Type 1 fimbriae Preclinical (in vitro) Han Z, et al. 2010. J Med Chem
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2 



Back to top
2004-2024 NIPB, CAMS&PUMC